The Scope of the Problem
Malnutrition and muscle wasting (sarcopenia) affect 50–90% of patients with advanced cirrhosis, depending on the assessment method and population studied. Despite this prevalence, nutrition is frequently undertreated — partly because weight may appear preserved in patients with ascites, masking true lean body mass depletion.
The consequences are significant and well-documented:
- Sarcopenia is an independent predictor of waitlist mortality, separate from MELD
- Pre-transplant sarcopenia is associated with longer ICU stays, higher rates of infection, and worse long-term survival post-transplant
- Hepatic encephalopathy is worsened by both protein deficiency and excess
- Frailty (of which sarcopenia is a component) predicts 1-year waitlist mortality and is now assessed formally at many transplant centers using the Liver Frailty Index
Why Cirrhotic Patients Are Malnourished
Multiple mechanisms converge:
- Reduced intake: Early satiety from ascites, anorexia, dysgeusia (taste changes), nausea from medications
- Malabsorption: Portal hypertensive enteropathy, bacterial overgrowth, cholestasis impairing fat-soluble vitamin absorption
- Altered metabolism: Cirrhotics use fat as a preferential fuel substrate even in the fed state — they enter a "starvation-like" state more quickly than healthy individuals. Overnight fasting alone can cause significant catabolism.
- Protein catabolism: Hormonal dysregulation, systemic inflammation, increased gluconeogenesis from muscle amino acids
- Ascites management: Sodium restriction (often inappropriately also restricts calories) and diuretics
Assessment of Nutritional Status
Standard measures (BMI, serum albumin) are unreliable in cirrhosis:
- BMI is confounded by ascites and edema — body weight overestimates lean mass
- Albumin reflects hepatic synthetic function, not nutritional status, in liver disease
Better tools include:
- Royal Free Hospital-Global Assessment (RFH-GA): Validated tool for cirrhosis; combines BMI, mid-arm muscle circumference, and dietary intake
- Handgrip strength: Simple, reproducible, and predictive of clinical outcomes. A standardized measure of functional muscle strength.
- 6-minute walk test and Liver Frailty Index: Composite functional assessments increasingly used in pre-transplant settings
- CT-based sarcopenia assessment: Skeletal muscle index at L3 level on cross-sectional imaging — gold standard but not routinely ordered for nutritional purposes
Nutritional Targets in Cirrhosis
ESPEN and EASL guidelines recommend:
- Energy: 35–40 kcal/kg ideal body weight per day
- Protein: 1.2–1.5 g/kg ideal body weight per day — higher than previously thought. Protein restriction is not recommended and is actively harmful. Even in hepatic encephalopathy, protein intake should be maintained (treat HE with lactulose/rifaximin, not protein restriction).
- Branched-chain amino acids (BCAAs): Supplementation (leucine, isoleucine, valine) has evidence for improving muscle mass, HE, and survival in specific populations
- Late evening snack: Consuming 50g carbohydrate (or equivalent) before sleep reduces overnight fasting catabolism. This is a simple, evidence-based recommendation with real impact on nitrogen balance.
- Sodium restriction: 2g/day for ascites management. Important not to conflate this with caloric restriction — sodium restriction doesn't mean food restriction.
Micronutrient Deficiencies
Common and clinically significant:
- Zinc: Deficiency contributes to HE and immune dysfunction. Supplementation may reduce HE frequency.
- Fat-soluble vitamins (A, D, E, K): Impaired absorption in cholestatic disease. Vitamin D deficiency is nearly universal in cirrhosis and associated with bone disease and immune dysfunction.
- B vitamins (thiamine, folate, B12): Critical in alcohol-related disease. Thiamine deficiency → Wernicke's encephalopathy — always replete before administering glucose in alcohol-related disease.
- Magnesium, phosphorus: Common electrolyte deficiencies, worsened by diuretic use
Practical Interventions
- Refer to a registered dietitian with hepatology experience at first decompensation
- Oral nutritional supplements (ONS) for patients unable to meet caloric needs by diet alone
- Nasogastric tube feeding if oral intake is severely limited (safe in cirrhosis; does not significantly increase bleeding risk in absence of active variceal hemorrhage)
- Exercise rehabilitation: resistance exercise programs improve muscle mass and functional status in compensated cirrhosis and are increasingly studied in transplant candidates